[2]
Tan, L. Epidemiology of Parkinson’s disease. Neurol. Asia, 2013, 18(3), 231-238.
[15]
Yang, W.; Hamilton, J.L.; Kopil, C.; Beck, J.C.; Tanner, C.M.; Albin, R.L.; Ray Dorsey, E.; Dahodwala, N.; Cintina, I.; Hogan, P.; Thompson, T. Current and projected future economic burden of Parkinson’s disease in the US. npj. Parkinsons Dis., 2020, 6(1), 1-9.
[33]
Harish, K.; Varghese, T. Probiotics in humans-evidence based review. Calicut Med. J., 2006, 4(4), e3.
[41]
Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the human intestinal microbial flora. Science, 2005, 308(5728), 1635-1638.
[43]
Foster, J.; Neufeld, K.A. Gut-brain axis: How the microbiome influences anxiety and depression. Int. J. Neuropsychopharmacol., 2014, 17, 27.
[72]
Singleton, AB; Farrer, M; Johnson, J; Singleton, A; Hague, S; Kachergus, J; Hulihan, M; Peuralinna, T; Dutra, A; Nussbaum, R Lincoln, S α-synuclein locus triplication causes Parkinson's disease. Science, 2003, 302(5646), 841.
[97]
Hooper, LV; Littman, DR; Macpherson, AJ. Interactions between the microbiota and the immune system. Science, 2012, 336(6086), 1268-1273.
[125]
Scotti, E; Boué, S; Sasso, GL; Zanetti, F; Belcastro, V; Poussin, C; Sierro, N; Battey, J; Gimalac, A; Ivanov, NV; Hoeng, J Exploring the microbiome in health and disease: Implications for toxicology. Toxicology Research and application, 2017, 1, 2397847317741.
[129]
Kianifar, HR; Farid, R; Ahanchian, H Probiotics in the treatment of acute diarrhea in young children.,
[163]
Nivetha, A.; Mohanasrinivasan, V. Mini review on role of β-galactosidase in lactose intolerance. IOP Conference Series: Mater. Sci. Eng., 2017, 263(2), p. 022046.
[184]
Sveje, M. Probiotic and prebiotics-improving consumer health through food consumption., Nutracoss, 2007, 28-31.